ABSTRACT
During antibiotic persistence, bacterial cells become transiently tolerant to antibiotics by restraining their growth and metabolic activity. Detailed molecular characterization of antibiotic persistence is hindered by low count of persisting cells and the need for their isolation. Here, we used sustained addition of stable isotope-labeled lysine to selectively label the proteome during hipA-induced persistence and hipB-induced resuscitation of Escherichia coli cells in minimal medium after antibiotic treatment. Time-resolved, 24-h measurement of label incorporation allowed detection of over 500 newly synthesized proteins in viable cells, demonstrating low but widespread protein synthesis during persistence. Many essential proteins were newly synthesized, and several ribosome-associated proteins such as RaiA and Sra showed high synthesis levels, pointing to their roles in maintenance of persistence. At the onset of resuscitation, cells synthesized the ribosome-splitting GTPase HflX and various ABC transporters, restored translation machinery, and resumed metabolism by inducing glycolysis and biosynthesis of amino acids.
IMPORTANCE While bactericidal antibiotics typically require actively growing cells to exploit their function, persister cells are slowly replicating which makes them tolerant to the lethal action of antimicrobials. Here, we used an established in vitro model of bacterial persistence based on overexpression of the paradigm toxin-antitoxin (TA) system hipA/hipB to devise a generic method for temporal analysis of protein synthesis during toxin-induced persistence and antitoxin-mediated resuscitation. Our time-resolved, 24-h measurement of label incorporation demonstrated low but widespread protein synthesis during persistence. At the onset of resuscitation, cells restored translation machinery and resumed metabolism by inducing glycolysis and biosynthesis of amino acids. Our study provides the first global analysis of protein synthesis in persisting and resuscitating bacterial cells, and as such, presents an unprecedented resource to study the processes governing antibiotic persistence.
KEYWORDS: SILAC, bacteria, persistence, proteomics, resuscitation
INTRODUCTION
Antibiotic resistance is an acute health problem. Many bacteria are categorized as serious threats representing a considerable clinical and financial burden (1, 2). In addition to resistance, bacteria also possess an elusive innate strategy, termed persistence, that enables them to tolerate antibiotics without acquiring genetic changes (3). Persisters are defined as phenotypic variants of bacterial cells that become transiently tolerant to antibiotics by restraining their growth and entering a dormant-like state (4, 5). Persistence is exhibited within a subpopulation of genetically uniform cells, a phenomenon present in all bacteria tested so far (6, 7). While bactericidal antibiotics typically require actively growing cells to exploit their function, persister cells are slowly replicating which makes them tolerant to the lethal action of antimicrobials. In addition to slow growth, the persister phenotype is also associated with very low metabolic activity (8, 9).
Persistence can be induced by toxin-antitoxin (TA) modules that usually consist of two genes: one encoding a toxin that inhibits cell growth and another encoding an antitoxin that inhibits toxin activity (10, 11). While the product of the toxin gene is a protein that interferes with essential cellular functions, antitoxin genes encode either small proteins or noncoding RNAs (10). Several studies have shown that persister cultures are heterogenous, with large abundance of cells with intact membranes that are viable but nonculturable (VBNC) (12–15). In addition, low counts of persister cells in these cultures necessitate application of elaborate protocols for their isolation (16–18), making detailed, unbiased exploration of the unperturbed molecular processes a challenging task.
Here, we used an in vitro model of bacterial persistence based on conditional overproduction of HipA toxin and HipB antitoxin (19–24) to devise a generic method for temporal analysis of protein synthesis during toxin-induced persistence and antitoxin-mediated resuscitation. The bacterial serine-threonine protein kinase HipA promotes multidrug tolerance by phosphorylating the glutamate-tRNA ligase (GltX), leading to a halt in translation, inhibition of growth, and induction of a physiologically dormant state (persistence) (19–21). We reasoned that prolonged antibiotic treatment of HipA-induced Escherichia coli cells, which results in a mixture of dead (lysed) and viable cells, can be coupled with the sustained addition of stable isotope-labeled amino acids directly to the culture. As only the viable, persisting cells are capable of incorporating the label and the label mass shift can be easily resolved in a mass spectrometer, this approach can be used to selectively label and detect newly synthesized proteins in the high background of proteins originating from dead cells. For simplicity, in this paper, we will use the term “persisters” for all cells that remain viable after this treatment; however, we note that this population is heterogenous and consists of culturable persisters and viable but nonculturable cells. Similar strategies, termed “pulsed” or “dynamic” stable isotope labeling by amino acids in cell culture (SILAC), have previously been used to analyze protein turnover in eukaryotic (25, 26) and prokaryotic cells (27, 28).
RESULTS
HipA-induced persister cells show low but measurable protein synthesis.
To test applicability of our approach, we first increased the number of persister cells growing in minimal medium by ectopically inducing hipA in E. coli MG1655. Three hours after HipA-induced growth inhibition, we treated the culture with ampicillin to lyse antibiotic-sensitive cells. During ampicillin treatment, we repressed expression of hipA by the addition of glucose to prevent constant HipA overproduction. Twenty hours after ampicillin treatment, we added 15N213C6-lysine (Lys8) to the culture; this time point was sufficient to eradicate sensitive cells and achieve a steady state of persistence, as demonstrated by approximately 1,000-fold higher count of CFU in the hipA-induced strain compared to the empty vector (see Fig. S1A and B in the supplemental material). After introduction of the Lys8 label, we harvested the culture aliquots by brief centrifugation to pellet intact cells in three biological replicates at multiple time points ranging from 10 min to 24 h (Fig. 1A). In this experimental setup, only viable cells incorporated Lys8, which enabled specific detection of newly synthesized proteins, temporal quantification of protein abundance, and estimation of protein half-lives (see Fig. S1C and Data Set S1, sheet 1, in the supplemental material). The number of identified proteins across time points was consistent, with 1,993 proteins identified on average at each time point (Fig. S1D). Remarkably, up to 531 proteins have partially incorporated the Lys8 label and were reproducibly quantifiable in the high background of Lys0-labeled proteins originating from dead cells (Fig. S1D and S1E). Due to HipA-mediated inhibition of cell growth, incorporation of Lys8 in these proteins was only partial and expected to be very low; 24 h after the start of labeling, the average intensity of all heavy labeled signals amounted to only 8.64% of the total ion intensity (Fig. 1B). Nevertheless, the measurable label incorporation was indicative of protein synthesis in viable cells and was in agreement with previous studies (28–30). The low level of label incorporation reflected the low turnover rates and long half-lives of proteins in persisting cells. Estimation of protein half-lives from the measured heavy/light (H/L) ratios as described previously (25) revealed that the median protein half-life under these conditions was longer than 250 h (Fig. S1G and Data Set S1, sheet 1). This, however, is only an estimate, since our measurement window (24 h) was significantly shorter than the actual protein half-life, and our calculation was based on the assumption of complete cell growth arrest. This experiment demonstrated that it is possible to partially label and directly detect newly synthesized proteins of viable cells after toxin overproduction and antibiotic treatment. All measured proteins and their ratios are listed in Data Set S1, sheet 2, and can be browsed online at https://pctsee.pct.uni-tuebingen.de.
Persisting bacteria produce proteins needed for essential cellular processes.
For further data analysis, the time points over the entire 24-h course of persistence were collapsed into six time bins, and proteins were ranked based on their H/L ratios. Gene Ontology (GO) analysis of all newly synthesized proteins showed that proteins involved in translation, glycolysis, protein targeting, redox homeostasis, and tricarboxylic acid cycle were significantly enriched (P < 0.01) (Data Set S1, sheet 3). Importantly, almost all ribosomal proteins were overrepresented among the top 25% proteins that exhibited relatively high label incorporation across all time points (P = 1.67E−15). In contrast, proteins with lower label incorporation (bottom 25%) participate mainly in the metabolic pathways such as biosynthesis of amino acids and other metabolites (Fig. 1C). Interestingly, enzymes involved in protein degradation, including degradation of antitoxins necessary to maintain an optimal toxin/antitoxin ratio during persistence, also exhibited higher label incorporation. They included several proteases (Lon, HslU, HslV, and HtpX), as well as the specificity components of the Clp protease (ClpA and ClpX, but not ClpP), implying that protein degradation is active during persistence (Fig. 1D). Two antitoxins, PrlF and MqsA, as well as several heat and cold shock proteins involved in stress response, also showed Lys8 incorporation. Furthermore, proteins involved in transcription, such as the ribonucleases RNase R (Rnr) and RNase III (Rnc) required for RNA processing and turnover, including the RNA polymerase sigma factor RpoD, were also detected as newly synthesized, as were several translation regulatory proteins essential for the start of protein synthesis, such as translation initiation factors IF-1 and IF-3 (InfA and InfC) (Fig. 1E). Several chaperones were detected as newly synthesized during persistence (Fig. 1F), suggesting that they may be required for the maintenance of proteome homeostasis, either by enabling correct folding of misfolded client proteins or by targeting unfolded (or aggregated) proteins for degradation. Among them were DnaK, DnaJ, and ClpB, that were previously connected to persistence (31, 32). Moreover, one of the most important DNA repair proteins RecA was identified as newly synthesized in our study, which is in agreement with a previous report that SOS response genes are expressed during persistence due to inhibited DNA replication (32). These results indicate that bacterial cells perform active translation during antibiotic persistence and produce proteins that are needed for essential cellular processes. In fact, out of 299 essential gene products in E. coli, 159 incorporated the label during persistence (Data Set S1, sheet 4).
Ribosome-associated proteins RaiA and Sra show elevated synthesis levels during persistence.
Consistent with the slow growth attributed to persister cells, proteins required for cell division (FtsH, FtsZ, FtsY, and ZipA) were either not detected or displayed very low label incorporation in our data set, suggesting that residual cell growth is still present but is extremely slow. Accordingly, chemotaxis-related proteins that are important for cell motility were not identified, which supports the absence of cell movement during persistence. The low abundance of newly synthesized proteins involved in metabolism, mainly in biosynthesis of amino acids and primary carbon metabolism, demonstrated that major energy-generating pathways are active in our model of persistence, but their activity is very low. In contrast to reduced metabolism and cell division, we found that ribosomal proteins and general stress response-related proteins were incorporating the Lys8 label to a higher extent during persistence.
Regulation of ribosome function is known to have a key role in bacterial persistence (33); therefore, we next analyzed relative abundance and label incorporation of all detected ribosomal proteins, as well as ribosome-associated hibernation and stationary-phase factors proposed to modulate ribosomal activity, such as EttA, RaiA, ElaB, YqjD, and Sra (33–35). In persisting cells, measured rates of label incorporation and relative abundances of most ribosomal proteins were relatively high (Fig. 2A). Of hibernation factors, only RaiA was detected as newly synthesized at a relatively high rate, pointing to its potential role as a major factor in active maintenance of ribosome hibernation during persistence. Intriguingly, the stationary-phase ribosome-associated factor Sra showed an even higher label incorporation rate (Fig. 2A). Importantly, the level of newly synthesized GTPase HflX, proposed to mediate activation of hibernating ribosome dimers (36), was not detectable during persistence. Strikingly, the overall abundance of newly synthesized hibernation factors (predominantly RaiA), estimated using intensity-based absolute quantification (iBAQ) of the heavy isotope channel, was about 100-fold higher than the level of all newly synthesized ribosomal proteins combined (Fig. 2B and Data Set S1, sheet 5).
Ribosome-associated protein Sra is involved in antibiotic tolerance.
To analyze potential involvement of Sra and RaiA in the HipA-induced growth inhibition, we induced hipA in the sra and raiA deletion mutants at the beginning of the exponential phase and followed their growth over time (Fig. 2C and Fig. S1G). While the raiA mutant showed a growth curve comparable to that of the wild type (WT) upon hipA induction (Fig. 2C), the sra mutant showed a stronger inhibition, which could be partially complemented with a plasmid bearing sra with its native promoter (Fig. 2C). To further test whether ribosome-associated proteins Sra and RaiA influence HipA-induced persistence and antibiotic tolerance, we ectopically induced hipA in E. coli sra and/or raiA deletion strains in log phase and treated the cultures grown in LB medium with ampicillin for up to 48 h. Already 24 h after the addition of antibiotic, the CFU counts of the HipA-producing sra and raiA mutants were lower than the hipA-expressing WT, pointing to a lower tolerance of these strains to ampicillin (Fig. 2D and Fig. S1H). A similar effect was also observed in M9 minimal medium (Fig. S1I). The difference in the CFU count was even more pronounced 48 h after the addition of antibiotic, with the CFU count of the raiA mutant about 100-fold lower and that of the sra mutant 1,000-fold lower than that of the WT. A less pronounced but similar trend was also observed when hipA was not induced (Fig. 2E). These experiments strongly suggested involvement of ribosome-associated proteins, especially Sra, in the maintenance of antibiotic tolerance.
HipB production leads to rapid resuscitation and incorporation of the Lys8 label.
We next applied our approach to study proteins produced upon induction of resuscitation. As in the first experiment, we increased the number of persister cells by ectopically inducing hipA in minimal medium supplemented with Lys0 and treated the culture with a high dose of ampicillin. We repressed expression of hipA during ampicillin treatment by adding glucose to ensure steady-state conditions independent of any HipA overproduction. To trigger resuscitation, we removed ampicillin, Lys0, and cellular debris of lysed cells by gentle filtration and added fresh minimal medium containing β-d-1-thiogalactopyranoside (IPTG) to induce transcription of hipB to produce HipB antitoxin. The medium also contained “heavy” lysine (Lys8) for metabolic labeling of resuscitating cells. Filtered cultures exposed to the fresh, IPTG-containing medium resumed growth, whereas unfiltered control cultures did not (Fig. S2A), demonstrating that resuscitation was driven by hipB induction. The resuscitating culture was harvested in three biological replicates and 20 time points (Fig. 3A). Incorporation of Lys8 in resuscitating cells followed the shape of the growth curve and saturated at average 94.6% (Fig. 3B). By 30 min after induction of resuscitation, more than 100 proteins incorporated the Lys8 label and could be quantified. Although the median of Lys8 incorporation during the first 4 h was low (<8%), the presence of outliers indicated that a subset of proteins such as NemA, FrmB, and BhsA incorporated the label faster than others and are therefore likely to play a role in resuscitation (Data Set S1, sheet 6). On average, 1,880 proteins were identified at an estimated false discovery rate (FDR) of 1.3% (Fig. S2B). The three biological replicates showed good reproducibility of measured protein SILAC ratios across all time points (Fig. S2C).
To analyze processes occurring early during resuscitation, we considered time points from the first 8 h of hipB induction, in which the optical density doubled. Measured protein ratios were collapsed into five time bins, and proteins were ranked based on their H/L ratio within each time bin. According to the KEGG pathway enrichment analysis, proteins exhibiting high label incorporation (top 25%) during the entire 8-h course of resuscitation are involved mainly in the biosynthesis and transport of amino acids, such as arginine and cysteine, as well as in alanine, aspartate, and glutamate metabolism (P value of <0.05). Conversely, proteins with a low label incorporation (bottom 25%) are constituents of the citric acid cycle and amino sugar and nucleotide sugar metabolism (Fig. 3C). Altogether, this implies that resuscitating bacteria are predominantly synthesizing enyzmes for anabolic pathways to produce building blocks for cell growth. Proteins involved in catabolic pathways that consume metabolites to release energy are synthesized at a lower rate compared to all quantified proteins. This is in agreement with our experimental design, as we were resuscitating cells with glucose as the carbon source. Therefore, most energy was derived from glucose catabolism (glycolysis), not from the catabolism of other metabolites.
The onset of resuscitation is marked by restoration of glycolysis and the translation machinery.
To identify proteins that are potentially regulating the switch from persistence to resuscitation, the first time bin (10 to 30 min) after induction of hipB was analyzed in more detail. GO enrichment analysis revealed that 43 out of 153 quantified proteins take part in translation (P = 2.75E−27), out of which 42 are ribosomal proteins and one is Sra (Data Set S1, sheets 7 and 8). Glycolysis pathway, stress response, and protein folding were also significantly enriched. This implies that, at the very onset of resuscitation, cells restored almost the entire translation machinery and restarted their metabolism by inducing glycolysis to convert glucose from the fresh medium into energy used for regrowth (Data Set S1, sheet 8). Several proteins showed unusually high label incorporation in the first 30 min after induction of resuscitation. As expected, among them was HipB antitoxin that was produced from the plasmid and therefore served as a positive control. Other proteins participate in various processes, such as the ribonucleotide monophosphatase NagD that dephosphorylates a wide range of (deoxy)ribonucleoside phosphates, or the S-formylglutathione hydrolase FrmB, which converts S-formylglutathione into formate and glutathione to detoxify formaldehyde that can otherwise chemically modify DNA and proteins (37). Among them were also several proteins known to play a role in persistence, such as the ATP-dependent Clp protease subunit ClpA that directs the ClpAP protease to specific substrates for their degradation (38, 39) (Fig. 3F) and the RNA polymerase sigma factors RpoS and RpoD. RpoS is important for transcriptional reprogramming of many genes that are mainly involved in the metabolism and stress response (39), whereas RpoD preferentially induces transcription of genes associated with fast growth, such as ribosomal proteins (40), which is in agreement with our findings (see below). Considering that RpoD was also detected during persistence, it can be assumed that it might have a dual role during both processes. Moreover, several other proteins were rapidly synthesized during early resuscitation, such as NemA, which reduces N-ethylmaleimide that inhibits growth by modifying cysteine residues of cellular proteins (41). NemA is also known to degrade toxic compounds to use them as a source of nitrogen (42) (Fig. S4).
Resuscitation is a concerted and tightly regulated biological process.
To obtain global insight into processes occurring during resuscitation, we performed statistical enrichment analysis of KEGG- and GO-annotated functions in each of the five time bins. Functions related to ribosome and protein biosynthesis were significantly enriched in all time bins, demonstrating that translation is the key process that dominates resuscitation. In addition, the following protein functions were overrepresented: bin 1 (10 to 30 min), glycolysis and chaperone-mediated protein folding; bin 2 (45 to 90 min), glycolysis and aminoacyl-tRNA synthetase; bin 3 (2 to 3 h), biosynthesis of antibiotics and amino acids; bin 4 (4 to 5 h) and bin 5 (6 to 8 h), biosynthesis of amino acids, antibiotics, and carbon metabolism (Data Set S1, sheet 8). For 1,663 proteins, we were able to measure label incorporation over all 21 measured time points. Unsupervised clustering of their temporal profiles revealed eight distinct clusters that differed markedly in the rate of label incorporation, estimated by the average time needed to incorporate 50% of the label (Fig. S3 and Data Set S1, sheet 9). Among proteins with fast label incorporation, functions such as “ABC transporters” and “arginine biosynthetic process” were overrepresented (“early functions”). They were followed by protein clusters enriched in diverse metabolic pathways and protein biosynthesis (“intermediate functions”). Proteins with the slowest label incorporation were predominantly involved in various catabolic processes; these “late functions” most likely do not play a role in resuscitation but may be of importance in the transition to stationary phase that was also covered in our analysis. Combined, this analysis revealed that resuscitation is a tightly regulated biological process that starts with activation of protein translation and synthesis of transporters needed to import nutrients and building blocks for protein biosynthesis.
Ribosomal hibernation factor HflX is induced in resuscitating cells.
Almost all detected ribosomal proteins showed synchronized label incorporation during resuscitation (Fig. 4A). Two notable exemptions were the ribosomal proteins L31-type B and L36-2, that showed markedly higher label incorporation compared to other ribosomal proteins. Approximately 10 h after hipB induction, the levels of these two proteins surpassed the levels of their paralogs L31 and L36, pointing to a rearrangement of the large ribosome subunit at the entry of the stationary phase (Fig. S2D). This observation, which was recently reported in another study (43), demonstrates the potential of the approach used to detect dynamics of protein complexes in a rapidly changing biological system. Resuscitation was also marked by induction of HflX that correlated with increased synthesis of ribosomal (and other) proteins (Fig. 4B and Data Set S1, sheet 10). Of note, the synthesis of other hibernation and stress factors such as RaiA and Sra did not diminish during resuscitation; however, as opposed to persisting cells, they were not in excess compared to newly synthesized ribosomal proteins.
DISCUSSION
Numerous studies have shown that bacterial persisters are transcriptionally and metabolically active (9, 13, 44, 45); however, protein synthesis during antibiotic persistence was so far rarely addressed (16, 28). Our study complements previous studies by providing a comprehensive and time-resolved analysis of protein synthesis and turnover during antibiotic persistence and, for the first time, during resuscitation.
In agreement with previous studies (27–29), we found that persister cells generated by ectopic HipA production are actively synthesizing new proteins during long-term ampicillin treatment, albeit at very low levels. During persistence, ribosomal proteins and major proteases involved in general protein turnover were predominantly synthesized, while proteins involved in anabolic pathways and cell division were barely detectable, as expected for a slow-growing or static cell population. RpoS, the sigma factor of the general stress response, was also synthesized at a detectable level, consistent with a condition requiring the production of factors essential in coping with the stress associated with cell stasis. Accordingly, RpoS-dependent factors were also produced, both during persistence and during resuscitation. Remarkably, we observed relatively high synthesis rates of regulatory factors associated with the translation apparatus, both during persistence (RaiA and Sra) and during resuscitation (Sra). During cell stasis and starvation, a large fraction (∼50%) of the ribosomes are known to be degraded, while another fraction is stabilized in an inactive state (46). Inactivation and stabilization of ribosomes during nutritional stress occur by at least two different mechanisms: (i) dimerization of 70S monomer ribosomes to 100S particles mediated by ribosome modulation factor (RMF) plus hibernation-promoting factor (HPF) (47, 48) or (ii) stabilization and inactivation of 70S monomer ribosomes by ribosome-associated inhibitor A (RaiA) (49–51). The findings that RaiA synthesis was significantly stimulated in persister cells and that the raiA deletion strain exhibited a lower level of HipA-induced persistence indicated that RaiA plays a role in persistence, probably by stabilizing ribosomes or by reducing translational errors (52) or both. The relatively mild phenotype exhibited by the raiA mutant strain during HipA-induced persistence may be due to the redundant mechanisms conferring ribosome stabilization during stasis. This proposal is supported by the observation that RaiA and HPF act synergistically to promote starvation survival in Vibrio cholerae (53). Similarly, the greatly elevated synthesis rate of Sra during persistence and resuscitation led us to test an sra deletion strain. In this case, the phenotype was even stronger during HipA-induced persistence, and the sra deletion strain also exhibited a reduced level of persistence compared to that of the WT even without the induction of hipA. Sra binds tightly to the 30S ribosomal subunit but is present at substochiometric levels relative to the ribosomes (∼1:10) in exponential growth, while this ratio increases in stationary phase (∼4:10) (54). Transcription of sra is stimulated in stationary phase by both (p)ppGpp, RpoS, and cyclic AMP (cAMP), factor for inversion stimulation (FIS), and integration host factor (IHF), consistent with the increased level relative to the ribosomes (54, 55). The absence of a clear phenotype of an sra deletion strain has previously made it difficult to understand the function of Sra (54, 56). Here, we present the first clear phenotype of a strain lacking Sra, an observation that may facilitate further analyses of the biological function of this protein. At the very onset of resuscitation, cells restored almost the entire translation machinery and restarted their metabolism by inducing glycolysis to convert glucose from the fresh medium into energy used for regrowth. Of note, we recently made a similar observation in resuscitation of chlorotic cyanobacteria (57), pointing to the existence of a common program for awakening of dormant-like cells. Two chaperones (DnaK and GroL) and transcription-related proteins (Rho, DeaD, and Pnp) that are involved in RNA metabolism and degradation were newly synthesized during early response, possibly regulating transcription of specific genes. Because these proteins were also detected to be synthesized during persistence, it is possible that the processes common to persistence are still active during the initial phase of the pulse-labeling. The delay in the wake-up from dormancy was observed previously and depends on several factors, such as the composition of the outgrowth medium or the frequency of persister cells (12, 58).
Molecular investigation of persistence is challenging, and we note that our approach is not free of experimental bias. Although the model that we used—induction of hipA and hipB genes of E. coli—has been extensively used in previous seminal studies of bacterial persistence (19–24), several uncertainties with this model still remain. First, after hipA induction, we used the lytic antibiotic ampicillin to enrich for persisters by physically eliminating sensitive cells; this treatment leads to a heterogenous population of cells that includes viable but nonculturable (VBNC) cells. Although VBNC cells and persister cells are both tolerant to ampicillin and according to some authors present a “dormancy continuum” (59), the exact nature of VBNC cells and their relationship to persisting cells are still debated (60). We note that our present experimental design does not allow us to discriminate between different kinds of persisting cells; however, in future experiments, dynamic SILAC can be combined with methods that can separate VBNC cells from viable, culturable cells and provide further insights into differences that underline these two cell types. Another, more general question is whether our hipBA model in combination with ampicillin treatment is representative of all bacterial persisters. As with every model, this is likely not the case; however, our results should be analyzed and interpreted in the context of several previous studies that used the same or similar model to investigate persistence (cited above).
On the technical end, a limitation of our approach is contamination of persister cells with the unlabeled pool of proteins that originate from dead (lysed) cells. Although these proteins can be easily discriminated according to the mass shift of their label, the resulting complexity of the mixture, in combination with a limited dynamic range of mass spectrometric detection, has led to decreased sensitivity of the measurements and lower proteome coverage compared to a usual shotgun proteomics experiment. This issue could be circumvented by an additional enrichment step to isolate persister cells from the batch culture, for example by using a long enzymatic treatment that targets the cell membrane (18) or centrifugation (30). However, such approaches would impose a significant stress to the cells, resulting in proteome changes that could finally lead to data misinterpretation. We cannot exclude the possibility that even gentle filtration of the bacterial culture, performed to induce resuscitation and introduce the Lys8 label, introduced some stress to the cell. The alternative could be persister isolation using flow cytometry based on green fluorescent protein (GFP) expression from plasmid carrying specific promoters of genes associated with dormancy, as reported previously (24, 61). Ideally, the enrichment should not be performed on living cells, but rather on isolated proteins that incorporated the label. For this, approaches based on click chemistry could be used, such as the metabolic labeling with methionine analogue l-azidohomoalanine (AHA) with subsequent attachment of an affinity tag to the reactive azide group and enrichment of the labeled proteins by affinity chromatography (62). However, in our experience, the application of AHA interferes significantly with translation and causes severe growth defects, which is not compatible with our study.
As mentioned above, application of labeled amino acids to study protein synthesis and turnover is often hampered by a limited dynamic range of detection in a mass spectrometer. This means that a very low level of label incorporation will not be detected in a high background of mass spectrometry (MS) signals originating from unlabeled peptides, making detection of label incorporation more likely in abundant proteins. Although the reasons for this are not only technical, as proteins involved in translation and essential proteins are usually abundant, this could be ameliorated by the addition of stable isotope-labeled peptide standards or even the whole-cell lysates as reported in previous analyses of low abundant posttranslational modifications (63). A further complication concerns the recycling of amino acids released from degradation of pre-existing proteins into the medium, which causes a dilution of the labeled amino acid pool with unlabeled amino acids and results in apparently lower turnover rates that cannot truly describe actual values. These values can be corrected using a recycling factor that can be calculated by measuring label incorporation in partially labeled missed cleaved peptides (25). Although these issues may influence the overall sensitivity and accurate estimation of individual protein turnover rates, we do not expect that they lead to a false detection of the newly synthesized proteins.
MATERIALS AND METHODS
Bacterial strains and plasmids.
E. coli strains and plasmids used in this study are listed in Table 1. Due to a high toxicity of HipA protein, the hipA gene was cloned into the expression plasmids together with a Shine-Dalgarno sequence in which the spacer between the Shine-Dalgarno sequence and the start codon was changed to decrease the translation efficiency of HipA (67). In Table 1, sd8 specifies a consensus sequence AAGGAA with a spacer of eight nucleotides to the GTG start codon. Oligonucleotides used are listed in Table 2.
TABLE 1.
Strain or plasmid | Genotype | Reference |
---|---|---|
Strains | ||
MG1655 | Wild-type E. coli K-12 | 64 |
ΔlysA | MG1655 ΔlysA::FRT P1 transduction from BW25113 lysA::FRT::aphA::FRT (Keio collection) into MG1655 and removed by flippase | This work |
sra::Kanr | MG1655 sra::FRT::aphA::FRT P1 transduction from BW25113 sra::FRT::aphA::FRT (Keio collection) into MG1655 | This work |
raiA::Kanr | MG1655 raiA::FRT::aphA::FRT P1 transduction from BW25113 raiA::FRT::aphA::FRT (Keio collection) into MG1655 | This work |
Plasmids | ||
pBAD33 | p15-derived expression plasmid, cat, araC, PBAD promoter, Cmr | 65 |
pNDM220 | R1-derived expression plasmid, pA1/O4/O3 (plac), lacIq, aphA (Kmr) | 69 |
pGOOD | pTrcHisB- and pACYC184-derived plasmid, lacI, TetR | 66 |
pBAD33::hipA (pEG5) | pBAD33 PBAD::sd8 gtg hipA | 19 |
pEG220::hipB | pEG220 Plac:: sdopt::hipB, Kmr | This work |
pGOOD::psra | pGOOD, sra and its native promoter cloned under lacI promoter upon digestion with BglII | This work |
TABLE 2.
Primer | Sequence (5′ to 3′) |
---|---|
EG287 | TTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTATATGGACAGCAAGCGAACCG |
EG288 | AGGTGGCACTTTTCGGGGAAATGTGCGCGGAACCCCTATTTGTTTATTTTTCTAAATACATCAGAAGAACTCGTCAAGAAG |
EM67 | GACTGGGCACAACAGACAAT |
EM68 | GGATGATCTGGACGAAGAGC |
EG239 | CATAGACTCGACATAAATCG |
EM172 | CCCCCGGATCCGTCGACTCAAGGAGTTTTATAAATGATGAGCTTTCAGAAGATCTA |
EM173 | CCCCCGAATTCTTACCACTCCAGATTTTGCTGTT |
raiA.del.KO-f | AGACGGGAAGACAAGAGGT |
raiA.del.KO-r | GCGTTGGCGATACACTCA |
sra.del.KO-f | CGCAGGCAATGGTGTTTAA |
sra.del.KO-r | CTACGGCGATGTTGTCCT |
psra.pGOOD-for | CGAAGGCGAAGCGGCATGCAGGTGCTATGCTTGATCGGCA |
psra.pGOOD-rev | CCCATATGGTACCAGCTGCATTACTTTTCAGCGGGGCGTT |
pGOOD.seq-for | GCCGCCAGGCAAATTCTGT |
pGOOD.seq2-rev | CATCACCGAAACGCGCGA |
The lysA::FRT::Kan::FRT deletion strain from the Keio collection (68) was P1 transduced into E. coli MG1655. The resulting mutation was verified by PCR diagnostics using primers EG239 and EG240 and then transformed with pCP20 to induce the flippase which removes the Kanr resistance cassette by recombination, resulting in MG1655 lysA::FRT mutant. The sra::FRT::Kan::FRT and sra::FRT::Kan::FRT deletion strains from the Keio collection (68) were P1 transduced into strain MG1655.
Plasmid pEG220 was constructed to change the kanamycin cassette of the expression plasmid pNDM220 (69) to ampicillin. The ampicillin cassette was amplified with primers EG287 and EG288 from pKD4. Then, DY331 strain has been electroporated with PCR fragment following the procedure from D. Court’s laboratory (https://redrecombineering.ncifcrf.gov/protocols/). The correct insertion of the ampicillin cassette has been verified using primer EM67 and EM68 matching in the insertion in the pNDM220. Then, the kanamycin cassette and the surrounding region of the newly constructed pEG220 were sequenced using primers EM67 and EM68.
For construction of plasmid pEG220::hipB, the hipB coding region with an optimized Shine-Dalgarno sequence was PCR amplified using primers EM172 and EM173. The resulting DNA fragment was digested with BamHI and EcoRI and ligated in pEG220 digested with the same enzymes.
For construction of plasmid pGOOD::psra, the plasmid was digested with BglI and Mph1103I, and the fragment containing the original lac promoter was removed. The fragment containing the sra gene and its native promoter was amplified with psra.pGOOD-for and -rev and inserted into the same sites. The plasmid was sequenced with pGOOD.seq-for and pGOODseq2-rev.
Persistence analysis.
A single colony was inoculated into liquid media (Luria broth or M9 minimal medium) supplemented with 0.4% glucose and 25 μg/ml chloramphenicol for maintenance of pBAD::hipA and grown overnight. When necessary, 50 μg/ml kanamycin was added for selection of sra::kan and raiA::kan. Overnight cultures were diluted to a starting OD600 (optical density at 600 nm) of 0.08; at an OD600 of 0.3, HipA was induced with 0.2% (wt/vol) l-(+)-arabinose for 1 h, followed by 100 μg/ml ampicillin (Fig. 2). For analysis in M9 medium, bacteria were grown to an OD600 of 0.4 and induced for 3 h with 0.2% (wt/vol) l-(+)-arabinose, followed by 100 μg/ml ampicillin (see Fig. S1 in the supplemental material). To analyze persisters under native HipA expression levels (Fig. 2), overnight cultures were diluted in LB at an OD600 of 0.08, followed by the addition of 100 μg/ml ampicillin at an OD600 of 0.5. Cells were harvested at the indicated time points (Fig. 1), pellets were washed with phosphate-buffered saline, and serial dilutions were plated on LB agar plates supplemented with 0.4% (wt/vol) glucose. Experiments were performed in triplicate. Data were visualized using Prism 8 (GraphPad).
P1 phage preparation and transduction.
A single colony of donor strain was inoculated in LB broth supplemented with 50 μg/ml of kanamycin and grown overnight. For lysate preparation, the overnight donor culture was diluted 1:100 into 5 ml of 0.2% (wt/vol) glucose and 5 mM CaCl2 and incubated 30 to 45 min at 37°C with shaking. One hundred microliters of P1 phage stock was added to the growing culture and incubated, with shaking, until the culture lysed (∼3 h). To complete cell lysis, about 150 μl of chloroform was added to the shaking culture. The culture was pelleted via centrifugation for 10 min at ∼9,200 × g at 4°C, and the supernatant containing the phages was filtered over a 0.45-μm sterile filter. For P1 transduction, the E. coli recipient strain was inoculated in 5 ml LB broth overnight at 37°C. The following day, 1.5 ml of the cell culture was pelleted by centrifugation for 2 min at maximum speed at room temperature, and the pellet was resuspended in P1 salt solution (10 mM CaCl2, 5 mM MgSO4), at half of the original volume. One hundred microliters of cells was mixed with different amounts of the desired P1 lysate (1, 10, and 100 μl), and the phage was allowed to adsorb for 30 min at room temperature. One milliliter of LB broth plus 200 μl of 1 M sodium citrate was added to the cell/phage mix and incubated for 1 h at 37°C. Cultures were then centrifuged, supernatants were removed, and the pellets were resuspended in LB medium. Resuspended cells were plated on LB agar plates supplemented with 50 μg/ml kanamycin. Single colonies were streaked on fresh selective plates and confirmed by PCR.
Cell growth and SILAC labeling.
Cells were grown in 100 ml of M9 minimal medium (50 mM Na2HPO4, 22 mM KH2PO4, 8.6 mM NaCl, 18.7 mM NH4Cl, 1 mM MgSO4, 0.1 mM CaCal2, 0.0001% [wt/vol] thiamine) supplemented with 0.4% (vol/vol) glycerol, 25 μg/ml chloramphenicol for maintenance of the pBAD33::hipA plasmid, and 50 μg/ml kanamycin for maintenance of pEG220::hipB plasmid. Cultures were grown in batch at 37°C shaking at 200 rpm. Overnight cultures were prepared from a single colony and grown for 20 h in M9 medium supplemented with 0.4% (wt/vol) d-(+)-glucose to repress the PBAD promoter. Overnight cultures were diluted to an OD600 of 0.01 to 0.02 in fresh M9 medium without glucose and antibiotics. For HipA-induced persistence, wild-type E. coli K-12 MG1655 strain was used. The expression of hipA was induced with 0.2% (wt/vol) l-(+)-arabinose at an OD600 of ≈0.4. After 3 h of hipA expression, cultures were treated with 100 μg/ml ampicillin for 19 to 22 h to kill nonpersister cells and 0.4% glucose to repress transcription of the PBAD::hipA promoter fusion. A pulse of 0.025% (wt/vol) stable isotope-labeled lysine derivative 13C615N2 l-lysine (“heavy” lysine, Lys8, and K8; Cambridge Isotope Laboratories) was then added in the presence of ampicillin, and 2-ml portions of cultures were harvested in intermittent time intervals (10 min to 24 h) by centrifugation at 4°C. A time point before the pulse of Lys8 (0 h) was harvested as a control. For the resuscitation experiment, an MG1655-derived strain lacking lysA (ΔlysA) was used. Growth media were supplemented with 0.025% (wt/vol) natural l-lysine (“light” lysine, Lys0, and K0; Sigma-Aldrich). The expression of hipA was induced with 0.2% (wt/vol) arabinose at an OD600 of ≈0.4. After 3 h of hipA expression, cultures were treated with 0.4% glucose and 100 μg/ml ampicillin for around 22 h. To induce resuscitation, cultures were first quickly filtered using prewarmed 1-liter Corning filter system (0.22-μm pore size) to remove ampicillin, Lys0, and dead cells. Immediately after, cells were quickly recovered in prewarmed medium supplemented with 25 μg/ml chloramphenicol, 50 μg/ml kanamycin, 0.4% glucose, 0.025% Lys8, and 2 mM β-d-1-thiogalactopyranoside (IPTG) for the induction of the Plac::hipB fusion. Cells were harvested at intermittent time intervals (10 min to 30 h) by centrifugation at 4°C. A time point before filtering and Lys8 pulse (0 h) was harvested as a control.
Cell lysis and sample preparation.
Collected cell pellets were lysed in a lysis buffer (40 mg/ml sodium dodecyl sulfate [SDS], 100 mM Tris-HCl [pH 8.6], 10 mM EDTA, and Complete protease inhibitors [Roche; 1 tablet per 10 ml]) and sonicated three times for 30 s at 40% amplitude. The cellular debris was pelleted by centrifugation at 15,000 × g for 30 min at room temperature, and proteins were precipitated from the supernatant with chloroform and methanol. Protein pellets were dissolved in a denaturation buffer (6 M urea, 2 M thiourea, and 10 mM Tris [pH 8.0]). Protein concentration was determined using standard Bradford assay (Bio-Rad). A 10-μg protein aliquot from each time point was reduced using 1 mM dithiothreitol for 1 h and alkylated with 5.5 mM iodoacetamide for an additional hour in the dark. Proteins were digested with endoproteinase Lys-C (1:100 [wt/wt]) for 3 h, diluted with 4 volumes of 20 mM ammonium bicarbonate (pH 8.0), and digested overnight with Lys-C (1:100 [wt/wt]) at room temperature. The reaction was stopped by lowering pH to 2 with trifluoroacetic acid. Peptides were purified via stage tips (70) as described previously (20). Briefly, before each liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) measurement, samples were desalted and purified on reversed-phase C18 stage tips (Empore), in-house prepared, previously activated with methanol, and equilibrated with solvent A* (2% [vol/vol] acetonitrile, 1% [vol/vol] formic acid in water). Up to 10 μg of peptides was loaded onto the membrane, washed with solvent A (0.1% [vol/vol] formic acid in water), and then eluted with 50 μl of solvent B (80% [vol/vol] acetonitrile and 0.1% [vol/vol] formic acid in water) and concentrated by vacuum centrifugation. The sample volume was adjusted with solvent A and final 10% (vol/vol) of solvent A*.
LC-MS/MS measurement.
Samples from each time point were separated by the EASY-nLC 1200 system (Thermo Scientific). Peptide separation was performed by reversed-phase chromatography on the in-house packed analytical column (20 cm × 75 μm, 1.9 μm ReproSil-Pur C18-AQ particles [Dr. Maisch]). Peptides were loaded onto the column at a flow rate of 700 nl/min of solvent A (0.1% [vol/vol] formic acid), and a constant temperature of 40°C under maximum back-pressure of 850 bars. Peptides were eluted using 116-min segmented gradient of 10 to 50% solvent B at a flow rate of 200 nl/min. Peptides were infused directly from the column tip into the on-line coupled Q Exactive HF mass spectrometer (Thermo Scientific) using a nanoelectrospray ion source (Thermo Scientific) at a voltage of 2.3 kV and a temperature of 275°C. Positively charged peptides were analyzed in a data-dependent acquisition mode, in which one full scan and subsequent MS/MS scans of 12 (Top12 method) most abundant precursors (isolation window of 1.4 m/z) were recorded in a mass range from 300 to 1,650 m/z. To prevent repeated fragmentation, the masses of sequenced precursors were dynamically excluded for 30 s. Only precursors with assigned charge states of ≥2 and ≤5 were considered for fragmentation selection. Full scans were acquired with a resolution of 60,000 at m/z 200, the maximum injection time of 25 ms, and the automatic gain control (AGC) target value of 3 × 106 charges. The higher energy collisional dissociation (HCD) fragmentation was achieved at normalized collision energy of 27% and intensity threshold of 1 × 105. MS/MS spectra were acquired with a resolution of 30,000, the maximum injection time of 45 ms, and the AGC target value of 1 × 105 charges.
MS data processing and analysis.
Acquired raw data were processed with MaxQuant software (version 1.5.2.8) (71) using the default settings if not stated otherwise. Raw files of particular experiments were processed separately. The built-in Andromeda search engines searched MS/MS spectra against fragment masses of peptides derived from an E. coli K-12 reference proteome (taxonomy identifier [ID] 83333) containing 4,324 entries (UniProt, release 2017/12) and a list of 245 common contaminants. The minimum required peptide length was set at 7 amino acids with the maximum of two missed cleavage sites allowed for endoproteinase Lys-C. For a protein to be quantified, two occurrences of the protein H/L ratio were required per time point (the multiplicity was set at two with Lys8 specified as the heavy label). Carbamidomethylation of cysteine was set as a fixed modification, and protein N-terminal acetylation and methionine oxidation as variable modifications. The precursor ion mass tolerance was set at 20 ppm in the first search and at 4.5 ppm in the main search. Peptide and protein identifications were filtered using a target-decoy approach with an estimated false discovery rate (FDR) of less than 1.3% at the protein level and less than 0.4% at the peptide level (72). Proteins identified by the same set of peptides were combined into a single protein group. For protein quantification, at least two peptide ratio counts were required.
Data analysis was performed using Microsoft Excel and Perseus software (version 1.5.6.0) (73). Nonnormalized protein H/L ratios from the MaxQuant proteingroup.txt result file were used for protein quantification. All contaminants, reversed hits, and proteins identified only by modification were removed. To simplify the data, the data sets from three biological replicate measurements were combined as a union, in which protein H/L ratios in each of the time points were kept if measured in only one replicate (class I), a mean was calculated if measured in two replicates (class II) or in three replicates (class III). To reduce the number of data points and missing values, time points were pooled into time bins. For that, the median protein H/L ratio of respective time points was calculated and assigned to a specific time bin. Proteins were then ranked based on their H/L ratio within each time bin and displayed in a heatmap-like representation sorted by the maximal H/L ratio across time bins. Gene annotation and KEGG enrichment analysis were performed using the DAVID tool (version 6.8) with default parameters and the background of all quantified proteins in particular experiments (74).
Temporal analysis of label incorporation.
MaxQuant processed data were imported in the R environment (75) to perform a time series analysis. The heavy label incorporation was calculated by dividing the heavy label intensity by the total (heavy plus light) intensity for each protein. Reverse hits, potential contaminants, and proteins identified only by sites were filtered out. The median of three replicates was computed per time points. Proteins with missing values were discarded from further analysis. The Euclidean distance between proteins was computed and used to generate the hierarchical clustering via Ward’s minimum distance using the stats R package. Time period resolution was achieved with minimal overlap when using eight cluster groups (k = 8). The resulting heatmap was drawn using the gplots R package (76), while cluster protein profiles over time were generated using the ggplot2 R package (77). For each cluster, the time needed to reach 50% heavy label incorporation was inferred by intersecting the 50% incorporation with the smoothed conditional mean. The list of proteins belonging to each cluster were imported into Perseus software suite (version 1.6.5.0) (73). The proteins were functionally annotated with Gene Ontology, KEGG, Pfam, GSEA, UniProt keywords, Corum, Interpro, Reactome, and EC functional resources. Each cluster was tested for function category over- or underrepresentation using a Fisher exact test (FDR ≤ 0.1).
Reactive web application for data browsing.
To allow the scientific community to browse our data sets, we developed a Shiny application coded entirely in the R programming language (78). Our application, called PCTsee, allows user to load different data sets, which are available through a drop-down widget. It is then possible to select gene name or protein ID of interest in order to display their abundance value. The abundance values have been computed by the MaxQuant software during LC-MS/MS data processing (e.g., intensity, ratio). The user selection will result in a protein abundance profile plot, as well as a table containing some information about the selected protein (e.g., protein names, sequence coverage). Users can interact further with the displayed plot to zoom, rescale, or remove samples due to the plotly R package (79). The PCTsee application is available at the following address: https://pctsee.pct.uni-tuebingen.de.
GO_term enrichment.
Gene ontology analysis of the proteins actively synthesized during resuscitation was performed with the online software DAVID (https://david.ncifcrf.gov/tools.jsp). Enrichment was performed comparing the gene names quantified proteins against the ones of identified proteins. DAVID was used with its preset with similarity overlap of 3 and threshold of 0.5, initial and final group membership of 3 and multiple linkage of 0.5, and enrichment thresohold at EASE 1.
Calculation of protein turnover rates.
Protein turnover rate (k) was calculated by linear regression of natural logarithm of protein SILAC H/L ratio over time as described previously (25) using the following equation independent of the growth rate:
where m is the number of time points () and is the protein H/L ratio measured in a time point . The half-life of a protein () was calculated by dividing the natural logarithm with the turnover rate k:
Protein H/L ratios derived from a union of three replicates were used for the calculation and only proteins with H/L ratio measured in >4 time points were considered. As a quality check of linear regression, the coefficient of determination (R2) was required to be >0.70 to ensure good curve fitting and reliable turnover rate estimation. All proteins with determined protein turnover rates are reported in Data Set S1, sheet 1, in the supplemental material.
Data availability.
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (80) partner repository with the data set identifier PXD018153. All other data needed to evaluate the conclusions in this paper are present in the paper or the supplemental material.
ACKNOWLEDGMENTS
We thank Karl Forchhammer for useful discussions and comments on the manuscript.
B.M. was supported by grants from the Deutsche Forschungsgemeinschaft (German Research Foundation Cluster of Excellence EXC 2124, SFB 766, FOR 2816, TRR 261), the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement 955626 and the German-Israeli Foundation grant I-1464–416.13/2018. K.G. was supported by a grant from the Danish National Research Foundation (grant identifier DNRF120) and the Novo Nordisk Foundation.
Contributor Information
Kenn Gerdes, Email: kenn.gerdes5@gmail.com.
Boris Macek, Email: boris.macek@uni-tuebingen.de.
Ileana M. Cristea, Princeton University
REFERENCES
- 1.Ventola CL. 2015. The antibiotic resistance crisis. Part 1: causes and threats. Pharm Ther 40:277–283. [PMC free article] [PubMed] [Google Scholar]
- 2.Brauner A, Fridman O, Gefen O, Balaban NQ. 2016. Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat Rev Microbiol 14:320–330. doi: 10.1038/nrmicro.2016.34. [DOI] [PubMed] [Google Scholar]
- 3.Van den Bergh B, Fauvart M, Michiels J. 2017. Formation, physiology, ecology, evolution and clinical importance of bacterial persisters. FEMS Microbiol Rev 41:219–251. doi: 10.1093/femsre/fux001. [DOI] [PubMed] [Google Scholar]
- 4.Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S. 2004. Bacterial persistence as a phenotypic switch. Science 305:1622–1625. doi: 10.1126/science.1099390. [DOI] [PubMed] [Google Scholar]
- 5.Lewis K. 2010. Persister cells. Annu Rev Microbiol 64:357–372. doi: 10.1146/annurev.micro.112408.134306. [DOI] [PubMed] [Google Scholar]
- 6.Balaban NQ. 2011. Persistence: mechanisms for triggering and enhancing phenotypic variability. Curr Opin Genet Dev 21:768–775. doi: 10.1016/j.gde.2011.10.001. [DOI] [PubMed] [Google Scholar]
- 7.Balaban NQ, Helaine S, Lewis K, Ackermann M, Aldridge B, Andersson DI, Brynildsen MP, Bumann D, Camilli A, Collins JJ, Dehio C, Fortune S, Ghigo J-M, Hardt W-D, Harms A, Heinemann M, Hung DT, Jenal U, Levin BR, Michiels J, Storz G, Tan M-W, Tenson T, Van Melderen L, Zinkernagel A. 2019. Definitions and guidelines for research on antibiotic persistence. Nat Rev Microbiol 17:441–448. doi: 10.1038/s41579-019-0196-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Radzikowski JL, Vedelaar S, Siegel D, Ortega ÁD, Schmidt A, Heinemann M. 2016. Bacterial persistence is an active sigmaS stress response to metabolic flux limitation. Mol Syst Biol 12:882. doi: 10.15252/msb.20166998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Amato SM, Fazen CH, Henry TC, Mok WWK, Orman MA, Sandvik EL, Volzing KG, Brynildsen MP. 2014. The role of metabolism in bacterial persistence. Front Microbiol 5:70. doi: 10.3389/fmicb.2014.00070. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Page R, Peti W. 2016. Toxin-antitoxin systems in bacterial growth arrest and persistence. Nat Chem Biol 12:208–214. doi: 10.1038/nchembio.2044. [DOI] [PubMed] [Google Scholar]
- 11.Harms A, Maisonneuve E, Gerdes K. 2016. Mechanisms of bacterial persistence during stress and antibiotic exposure. Science 354:aaf4268. doi: 10.1126/science.aaf4268. [DOI] [PubMed] [Google Scholar]
- 12.Jõers A, Kaldalu N, Tenson T. 2010. The frequency of persisters in Escherichia coli reflects the kinetics of awakening from dormancy. J Bacteriol 192:3379–3384. doi: 10.1128/JB.00056-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Orman MA, Brynildsen MP. 2013. Establishment of a method to rapidly assay bacterial persister metabolism. Antimicrob Agents Chemother 57:4398–4409. doi: 10.1128/AAC.00372-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Orman MA, Brynildsen MP. 2013. Dormancy is not necessary or sufficient for bacterial persistence. Antimicrob Agents Chemother 57:3230–3239. doi: 10.1128/AAC.00243-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Roostalu J, Jõers A, Luidalepp H, Kaldalu N, Tenson T. 2008. Cell division in Escherichia coli cultures monitored at single cell resolution. BMC Microbiol 8:68. doi: 10.1186/1471-2180-8-68. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Radzikowski JL, Schramke H, Heinemann M. 2017. Bacterial persistence from a system-level perspective. Curr Opin Biotechnol 46:98–105. doi: 10.1016/j.copbio.2017.02.012. [DOI] [PubMed] [Google Scholar]
- 17.Rowe SE, Conlon BP, Keren I, Lewis K. 2016. Persisters: methods for isolation and identifying contributing factors—a review. Methods Mol Biol 1333:17–28. doi: 10.1007/978-1-4939-2854-5_2. [DOI] [PubMed] [Google Scholar]
- 18.Cañas-Duarte SJ, Restrepo S, Pedraza JM. 2014. Novel protocol for persister cells isolation. PLoS One 9:e88660. doi: 10.1371/journal.pone.0088660. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Germain E, Castro-Roa D, Zenkin N, Gerdes K. 2013. Molecular mechanism of bacterial persistence by HipA. Mol Cell 52:248–254. doi: 10.1016/j.molcel.2013.08.045. [DOI] [PubMed] [Google Scholar]
- 20.Semanjski M, Germain E, Bratl K, Kiessling A, Gerdes K, Macek B. 2018. The kinases HipA and HipA7 phosphorylate different substrate pools in Escherichia coli to promote multidrug tolerance. Sci Signal 11:eaat5750. doi: 10.1126/scisignal.aat5750. [DOI] [PubMed] [Google Scholar]
- 21.Kaspy I, Rotem E, Weiss N, Ronin I, Balaban NQ, Glaser G. 2013. HipA-mediated antibiotic persistence via phosphorylation of the glutamyl-tRNA-synthetase. Nat Commun 4:3001. doi: 10.1038/ncomms4001. [DOI] [PubMed] [Google Scholar]
- 22.Correia FF, D’Onofrio A, Rejtar T, Li L, Karger BL, Makarova K, Koonin EV, Lewis K. 2006. Kinase activity of overexpressed HipA is required for growth arrest and multidrug tolerance in Escherichia coli. J Bacteriol 188:8360–8367. doi: 10.1128/JB.01237-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Korch SB, Hill TM. 2006. Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation. J Bacteriol 188:3826–3836. doi: 10.1128/JB.01740-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Schumacher MA, Balani P, Min J, Chinnam NB, Hansen S, Vulić M, Lewis K, Brennan RG. 2015. HipBA–promoter structures reveal the basis of heritable multidrug tolerance. Nature 524:59–64. doi: 10.1038/nature14662. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Schwanhäusser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, Chen W, Selbach M. 2011. Global quantification of mammalian gene expression control. Nature 473:337–342. doi: 10.1038/nature10098. [DOI] [PubMed] [Google Scholar]
- 26.Doherty MK, Hammond DE, Clague MJ, Gaskell SJ, Beynon RJ. 2009. Turnover of the human proteome: determination of protein intracellular stability by dynamic SILAC. J Proteome Res 8:104–112. doi: 10.1021/pr800641v. [DOI] [PubMed] [Google Scholar]
- 27.Chua SL, Yam JKH, Hao P, Adav SS, Salido MM, Liu Y, Givskov M, Sze SK, Tolker-Nielsen T, Yang L. 2016. Selective labelling and eradication of antibiotic-tolerant bacterial populations in Pseudomonas aeruginosa biofilms. Nat Commun 7:10750. doi: 10.1038/ncomms10750. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Spanka D-T, Konzer A, Edelmann D, Berghoff BA. 2019. High-throughput proteomics identifies proteins with importance to postantibiotic recovery in depolarized persister cells. Front Microbiol 10:378. doi: 10.3389/fmicb.2019.00378. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Sulaiman JE, Hao C, Lam H. 2018. Specific enrichment and proteomics analysis of Escherichia coli persisters from rifampin pretreatment. J Proteome Res 17:3984–3996. doi: 10.1021/acs.jproteome.8b00625. [DOI] [PubMed] [Google Scholar]
- 30.Pu Y, Zhao Z, Li Y, Zou J, Ma Q, Zhao Y, Ke Y, Zhu Y, Chen H, Baker MAB, Ge H, Sun Y, Xie XS, Bai F. 2016. Enhanced efflux activity facilitates drug tolerance in dormant bacterial cells. Mol Cell 62:284–294. doi: 10.1016/j.molcel.2016.03.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Hansen S, Lewis K, Vulić M. 2008. Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrob Agents Chemother 52:2718–2726. doi: 10.1128/AAC.00144-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Keren I, Shah D, Spoering A, Kaldalu N, Lewis K. 2004. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol 186:8172–8180. doi: 10.1128/JB.186.24.8172-8180.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Prossliner T, Skovbo Winther K, Sørensen MA, Gerdes K. 2018. Ribosome hibernation. Annu Rev Genet 52:321–348. doi: 10.1146/annurev-genet-120215-035130. [DOI] [PubMed] [Google Scholar]
- 34.Gohara DW, Yap MF. 2018. Survival of the drowsiest: the hibernating 100S ribosome in bacterial stress management. Curr Genet 64:753–760. doi: 10.1007/s00294-017-0796-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Yoshida H, Wada A. 2014. The 100S ribosome: ribosomal hibernation induced by stress. Wiley Interdiscip Rev RNA 5:723–732. doi: 10.1002/wrna.1242. [DOI] [PubMed] [Google Scholar]
- 36.Zhang Y, Mandava CS, Cao W, Li X, Zhang D, Li N, Zhang Y, Zhang X, Qin Y, Mi K, Lei J, Sanyal S, Gao N. 2015. HflX is a ribosome-splitting factor rescuing stalled ribosomes under stress conditions. Nat Struct Mol Biol 22:906–913. doi: 10.1038/nsmb.3103. [DOI] [PubMed] [Google Scholar]
- 37.Denby KJ, Iwig J, Bisson C, Westwood J, Rolfe MD, Sedelnikova SE, Higgins K, Maroney MJ, Baker PJ, Chivers PT, Green J. 2016. The mechanism of a formaldehyde-sensing transcriptional regulator. Sci Rep 6:38879. doi: 10.1038/srep38879. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Gottesman S, Roche E, Zhou Y, Sauer RT. 1998. The ClpXP and ClpAP proteases degrade proteins with carboxy-terminal peptide tails added by the SsrA-tagging system. Genes Dev 12:1338–1347. doi: 10.1101/gad.12.9.1338. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Battesti A, Majdalani N, Gottesman S. 2011. The RpoS-mediated general stress response in Escherichia coli. Annu Rev Microbiol 65:189–213. doi: 10.1146/annurev-micro-090110-102946. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Maciag A, Peano C, Pietrelli A, Egli T, De Bellis G, Landini P. 2011. In vitro transcription profiling of the σS subunit of bacterial RNA polymerase: re-definition of the σS regulon and identification of σS-specific promoter sequence elements. Nucleic Acids Res 39:5338–5355. doi: 10.1093/nar/gkr129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Miura K, Tomioka Y, Hoshi Y, Suzuki H, Yonezawa M, Hishinuma T, Mizugaki M. 1997. The effects of unsaturated fatty acids, oxidizing agents and Michael reaction acceptors on the induction of N-ethylmaleimide reductase in Escherichia coli: possible application for drug design of chemoprotectors. Methods Find Exp Clin Pharmacol 19:147–151. [PubMed] [Google Scholar]
- 42.Umezawa Y, Shimada T, Kori A, Yamada K, Ishihama A. 2008. The uncharacterized transcription factor YdhM is the regulator of the nemA gene, encoding N-ethylmaleimide reductase. J Bacteriol 190:5890–5897. doi: 10.1128/JB.00459-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Lilleorg S, Reier K, Pulk A, Liiv A, Tammsalu T, Peil L, Cate JHD, Remme J. 2019. Bacterial ribosome heterogeneity: changes in ribosomal protein composition during transition into stationary growth phase. Biochimie 156:169–180. doi: 10.1016/j.biochi.2018.10.013. [DOI] [PubMed] [Google Scholar]
- 44.Keren I, Minami S, Rubin E, Lewis K. 2011. Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. mBio 2:e00100-11. doi: 10.1128/mBio.00100-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Helaine S, Cheverton AM, Watson KG, Faure LM, Matthews SA, Holden DW. 2014. Internalization of Salmonella by macrophages induces formation of nonreplicating persisters. Science 343:204–208. doi: 10.1126/science.1244705. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Zundel MA, Basturea GN, Deutscher MP. 2009. Initiation of ribosome degradation during starvation in Escherichia coli. RNA 15:977–983. doi: 10.1261/rna.1381309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Franken LE, Oostergetel GT, Pijning T, Puri P, Arkhipova V, Boekema EJ, Poolman B, Guskov A. 2017. A general mechanism of ribosome dimerization revealed by single-particle cryo-electron microscopy. Nat Commun 8:722. doi: 10.1038/s41467-017-00718-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Wada A, Mikkola R, Kurland CG, Ishihama A. 2000. Growth phase-coupled changes of the ribosome profile in natural isolates and laboratory strains of Escherichia coli. J Bacteriol 182:2893–2899. doi: 10.1128/JB.182.10.2893-2899.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Agafonov DE, Kolb VA, Nazimov IV, Spirin AS. 1999. A protein residing at the subunit interface of the bacterial ribosome. Proc Natl Acad Sci USA 96:12345–12349. doi: 10.1073/pnas.96.22.12345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Agafonov DE, Kolb VA, Spirin AS. 2001. Ribosome-associated protein that inhibits translation at the aminoacyl-tRNA binding stage. EMBO Rep 2:399–402. doi: 10.1093/embo-reports/kve091. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Maki Y, Yoshida H, Wada A. 2000. Two proteins, YfiA and YhbH, associated with resting ribosomes in stationary phase Escherichia coli. Genes Cells 5:965–974. doi: 10.1046/j.1365-2443.2000.00389.x. [DOI] [PubMed] [Google Scholar]
- 52.Agafonov DE, Spirin AS. 2004. The ribosome-associated inhibitor A reduces translation errors. Biochem Biophys Res Commun 320:354–358. doi: 10.1016/j.bbrc.2004.05.171. [DOI] [PubMed] [Google Scholar]
- 53.Sabharwal D, Song T, Papenfort K, Wai SN. 2015. The VrrA sRNA controls a stationary phase survival factor Vrp of Vibrio cholerae. RNA Biol 12:186–196. doi: 10.1080/15476286.2015.1017211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Izutsu K, Wada C, Komine Y, Sako T, Ueguchi C, Nakura S, Wada A. 2001. Escherichia coli ribosome-associated protein SRA, whose copy number increases during stationary phase. J Bacteriol 183:2765–2773. doi: 10.1128/JB.183.9.2765-2773.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Lacour S, Landini P. 2004. SigmaS-dependent gene expression at the onset of stationary phase in Escherichia coli: function of sigmaS-dependent genes and identification of their promoter sequences. J Bacteriol 186:7186–7195. doi: 10.1128/JB.186.21.7186-7195.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Bubunenko M, Baker T, Court DL. 2007. Essentiality of ribosomal and transcription antitermination proteins analyzed by systematic gene replacement in Escherichia coli. J Bacteriol 189:2844–2853. doi: 10.1128/JB.01713-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Spät P, Klotz A, Rexroth S, Maček B, Forchhammer K. 2018. Chlorosis as a developmental program in cyanobacteria: the proteomic fundament for survival and awakening. Mol Cell Proteomics 17:1650–1669. 10.1074/mcp.RA118.000699. doi: 10.1074/mcp.RA118.000699. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Varik V, Oliveira SRA, Hauryliuk V, Tenson T. 2016. Composition of the outgrowth medium modulates wake-up kinetics and ampicillin sensitivity of stringent and relaxed Escherichia coli. Sci Rep 6:22308. doi: 10.1038/srep22308. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Ayrapetyan M, Williams TC, Oliver JD. 2015. Bridging the gap between viable but non-culturable and antibiotic persistent bacteria. Trends Microbiol 23:7–13. doi: 10.1016/j.tim.2014.09.004. [DOI] [PubMed] [Google Scholar]
- 60.Song S, Wood TK. 2021. 'Viable but non-culturable cells' are dead. Environ Microbiol 23:2335–2338. doi: 10.1111/1462-2920.15463. [DOI] [PubMed] [Google Scholar]
- 61.Shah D, Zhang Z, Khodursky A, Kaldalu N, Kurg K, Lewis K. 2006. Persisters: a distinct physiological state of E. coli. BMC Microbiol 6:53. doi: 10.1186/1471-2180-6-53. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Dieterich DC, Lee JJ, Link AJ, Graumann J, Tirrell DA, Schuman EM. 2007. Labeling, detection and identification of newly synthesized proteomes with bioorthogonal non-canonical amino-acid tagging. Nat Protoc 2:532–540. doi: 10.1038/nprot.2007.52. [DOI] [PubMed] [Google Scholar]
- 63.Weinert BT, Satpathy S, Hansen BK, Lyon D, Jensen LJ, Choudhary C. 2017. Accurate quantification of site-specific acetylation stoichiometry reveals the impact of sirtuin deacetylase CobB on the E. coli acetylome. Mol Cell Proteomics 16:759–769. doi: 10.1074/mcp.M117.067587. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Guyer M, Reed RR, Steitz JA, Low KB. 1981. Identification of a sex-factor-affinity site in E. coli as γδ. Cold Spring Harb Symp Quant Biol 45:135–140. doi: 10.1101/SQB.1981.045.01.022. [DOI] [PubMed] [Google Scholar]
- 65.Guzman LM, Belin D, Carson MJ, Beckwith J. 1995. Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J Bacteriol 177:4121–4130. doi: 10.1128/jb.177.14.4121-4130.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Conte E, Landolfi G, Vincelli G, Stefan A, Hochkoeppler A. 2011. pGOODs: new plasmids for the co-expression of proteins in Escherichia coli. Biotechnol Lett 33:1815–1821. doi: 10.1007/s10529-011-0624-6. [DOI] [PubMed] [Google Scholar]
- 67.Ringquist S, Shinedling S, Barrick D, Green L, Binkley J, Stormo GD, Gold L. 1992. Translation initiation in Escherichia coli: sequences within the ribosome-binding site. Mol Microbiol 6:1219–1229. doi: 10.1111/j.1365-2958.1992.tb01561.x. [DOI] [PubMed] [Google Scholar]
- 68.Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, Tomita M, Wanner BL, Mori H. 2006. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2:2006.0008. doi: 10.1038/msb4100050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Gotfredsen M, Gerdes K. 1998. The Escherichia coli relBE genes belong to a new toxin–antitoxin gene family. Mol Microbiol 29:1065–1076. doi: 10.1046/j.1365-2958.1998.00993.x. [DOI] [PubMed] [Google Scholar]
- 70.Rappsilber J, Mann M, Ishihama Y. 2007. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat Protoc 2:1896–1906. doi: 10.1038/nprot.2007.261. [DOI] [PubMed] [Google Scholar]
- 71.Cox J, Mann M. 2008. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26:1367–1372. doi: 10.1038/nbt.1511. [DOI] [PubMed] [Google Scholar]
- 72.Elias JE, Gygi SP. 2007. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat Methods 4:207–214. doi: 10.1038/nmeth1019. [DOI] [PubMed] [Google Scholar]
- 73.Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T, Mann M, Cox J. 2016. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods 13:731–740. doi: 10.1038/nmeth.3901. [DOI] [PubMed] [Google Scholar]
- 74.Huang DW, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44–57. doi: 10.1038/nprot.2008.211. [DOI] [PubMed] [Google Scholar]
- 75.R Core Team. 2018. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https://www.R-project.org.
- 76.Warnes GR, Bolker B, Bonebakker L, Gentleman R, Huber W, Liaw A, Lumley T, Maechler M, Magnusson A, Moeller S, Schwartz M, Venables B. 2019. gplots: various R programming tools for plotting data. R package version 3.0.1.1. https://CRAN.R-project.org/package=gplots.
- 77.Wickham H. 2016. ggplot2: elegant graphics for data analysis. https://ggplot2.tidyverse.org.
- 78.Chang W, Cheng J, Allaire JJ, Xie Y, McPherson J. 2019. Shiny: web application framework for R. https://CRAN.R-project.org/package=shiny.
- 79.Galili T, O’Callaghan A, Sidi J, Sievert C. 2018. heatmaply: an R package for creating interactive cluster heatmaps for online publishing. Bioinformatics 34:1600–1602. doi: 10.1093/bioinformatics/btx657. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Vizcaíno JA, Csordas A, del-Toro N, Dianes JA, Griss J, Lavidas I, Mayer G, Perez-Riverol Y, Reisinger F, Ternent T, Xu Q-W, Wang R, Hermjakob H. 2016. 2016 update of the PRIDE database and its related tools. Nucleic Acids Res 44:D447–D456. doi: 10.1093/nar/gkv1145. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (80) partner repository with the data set identifier PXD018153. All other data needed to evaluate the conclusions in this paper are present in the paper or the supplemental material.